Home
Kashiv BioSciences

Kashiv BioSciences Market Share Analysis for July 2026

Kashiv BioSciences is a fully-integrated biopharmaceutical company with global R&D, clinical, manufacturing, regulatory, and IP capabilities.

Industry: N/A

Domainkashivbiosciences.com

Year Founded2019

Employees201 - 500

Annual Revenue$25M - $50M

Kashiv BioSciences

Kashiv BioSciences (including company regionals)

kashivbiosciences.com

See more website traffic and engagement information

Kashiv BioSciences Revenue up to July 2026 is 25M - 50M

revenue generated by Kashiv BioSciences top domains

Kashiv BioSciences top domains revenue over 3 years

Revenue for Kashiv BioSciences top domains

kashivbiosciences.com25M - 50M

See more with Sales Intelligence

Total visits to Kashiv BioSciences's top domains

Understand Kashiv BioSciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

kashivbiosciences.com13.1K

See more with Sales Intelligence

Avg. visit duration in Kashiv BioSciences's top domains

Analyze Kashiv BioSciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

kashivbiosciences.com00:00:53

See more with Sales Intelligence

Avg. pageviews on Kashiv BioSciences's top domains

See how Kashiv BioSciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

kashivbiosciences.com2.02

See more with Sales Intelligence

Kashiv BioSciences top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Kashiv BioSciences

These are the website technologies, by industry, used by Kashiv BioSciences top domains

Content Management System (3)

WordPress

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

Advertising (1)

PubMatic

More Technologies

5

See all

News & Signals from Kashiv BioSciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlvotech partnered with Kashiv BioSciences LLC on Oct 1st '23.Under an exclusive licensing agreement with Kashiv entered in October 2023, Alvotech holds the commercialisation rights to ADL-018 (also referred to as AVT23) in Canada, together with the European Economic Area, UK, Switzerland, Australia and New Zealand.

NewsKashiv BioSciences LLC expands facilities to India, Southern Asia, Asia.Kashiv brings two facilities in India, one for manufacturing and another for R&D.

NewsAmneal Pharmaceuticals LLC acquired Kashiv BioSciences, LLC for $1.1B on Apr 22nd '26.Piscataway (New Jersey) [US], April 22: Kashiv BioSciences, LLC ("Kashiv"), today announced that it has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) ("Amneal").